PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

The STING of radiation

Ludwig researchers reveal the molecular mechanisms by which the immune system is activated against tumors treated with radiation

2014-11-20
(Press-News.org) November 20, 2014, Chicago, IL - A team of researchers led by Ludwig Chicago's Yang-Xin Fu and Ralph Weichselbaum has uncovered the primary signaling mechanisms and cellular interactions that drive immune responses against tumors treated with radiotherapy. Published in the current issue of Immunity, their study suggests novel strategies for boosting the effectiveness of radiotherapy, and for combining it with therapies that harness the immune system to treat cancer.

"Much of the conversation about the mechanisms by which radiation kills cancer cells has historically focused on the damage it does to DNA," says Weichselbaum, co-director of the Ludwig Center at the University of Chicago. "But it has recently become increasingly clear that the immune system plays an important--perhaps central--role in destroying tumors subjected to radiotherapy. Our study shows how radiation, DNA damage and the immune response that follows are linked."

Fu, Weichselbaum and their colleagues report that dendritic cells--among the immune system's primary reconnaissance forces--play a central role in the phenomenon. Through studies conducted in mouse models and cell cultures, they show that a protein within these cells named STING is key to activating the immune response to irradiated tumors. STING links the detection of small fragments of DNA to their production of an immune factor known as interferon-β (IFN-β). This factor boosts the ability of dendritic cells to activate the immune system's killer T cells, which destroy cancer cells.

Dendritic cells cruise the body looking for signs of infection or disease, using a variety of biochemical sensors that recognize general molecular patterns associated with different types of pathogens. One such detector, an enzyme known as cGAS, is activated by fragments of double-stranded DNA. cGas is a sensor of viral DNA that also senses damaged DNA from irradiated cells, thereby drawing the immune system into the host response to anti-tumor radiation.

The researchers show that cGAS in dendritic cells gets activated by such DNA fragments--an event that in turn switches on STING. This initiates a cascade of biochemical signals that culminates in the production of IFN-β, which promotes the activation of killer T cells by dendritic cells.

"This seems to be a fairly specific response in the context of radiation," says Weichselbaum. "If you knock out the STING gene in mice, their tumor growth is similar to that of normal mice. But, in the knock-out mice, the tumors are far more resistant to radiation than the tumors of control mice.

The team's experiments show that the dendritic cells from these STING knock-out mice fail to activate killer T cells following tumor irradiation. That capability, they find, can be restored by the addition of IFN-β.

Similarly, dendritic cells from mice whose cGAS genes were shut down or knocked out also failed to activate anti-tumor T cells. The cells regained that ability when given a dose of the molecules produced by cGAS that switch on STING signaling. Importantly, when those STING-activating molecules were injected into the tumors of normal mice, the tumors became very sensitive to radiation.

"These findings could open the door to improving cancer therapy," says Weichselbaum. "Drugs that activate STING signaling or the induction of IFN-β could be used to boost the effects of radiotherapy on tumors. Those effects might be observed in chemotherapy as well, since it too causes significant DNA damage."

In the longer term, says Weichselbaum, such molecules could be combined with existing killer T cell-boosting immunotherapies or cancer vaccines and radiation treatment to generate potent, systemic immune responses against metastatic cancers. He and his colleagues will be assessing these possibilities in mice.

INFORMATION:

This study was supported by the US National Institutes of Health, Ludwig Cancer Research and The Foglia Foundation.

About Ludwig Cancer Research

Ludwig Cancer Research is an international collaborative network of acclaimed scientists with a 40-year legacy of pioneering cancer discoveries. Ludwig combines basic research with the ability to translate its discoveries and conduct clinical trials to accelerate the development of new cancer diagnostics and therapies. Since 1971, Ludwig has invested more than $2.5 billion in life-changing cancer research through the not-for-profit Ludwig Institute for Cancer Research and the six U.S.-based Ludwig Centers.

For further information please contact Rachel Steinhardt, rsteinhardt@licr.org or +1-646-371-7394.



ELSE PRESS RELEASES FROM THIS DATE:

Antiangiogenic treatment improves survival in animal model of ovarian cancer

2014-11-20
BOSTON -- Epithelial ovarian cancer is the most lethal cancer of the female reproductive organs, with more than 200,000 new cases and more than 125,000 deaths each year worldwide. Because symptoms tend to be vague, 80 percent of these cancers are not recognized until the disease has advanced and spread to other parts of the body. The standard treatment for advanced ovarian cancer includes high-dose chemotherapy, which often results in debilitating side effects and for which the five-year survival rate is only 35 percent. Now new research in an animal model finds that ...

Biomarker could provide early warning of kidney disease in cats

Biomarker could provide early warning of kidney disease in cats
2014-11-20
CORVALLIS, Ore. - Researchers from Oregon State University and other institutions have developed a new biomarker called "SDMA" that can provide earlier identification of chronic kidney disease in cats, which is one of the leading causes of their death. A new test based on this biomarker, when commercialized, should help pet owners and their veterinarians watch for this problem through periodic checkups, and treat it with diet or other therapies to help add months or years to their pet's life. Special diets have been shown to slow the progression of this disease once ...

It's filamentary: How galaxies evolve in the cosmic web

Its filamentary: How galaxies evolve in the cosmic web
2014-11-20
RIVERSIDE, Calif. - How do galaxies like our Milky Way form, and just how do they evolve? Are galaxies affected by their surrounding environment? An international team of researchers, led by astronomers at the University of California, Riverside, proposes some answers. The researchers highlight the role of the "cosmic web" - a large-scale web-like structure comprised of galaxies - on the evolution of galaxies that took place in the distant universe, a few billion years after the Big Bang. In their paper, published Nov. 20 in the Astrophysical Journal, they present observations ...

Panel-based genetic diagnostic testing for inherited eye disease proves highly accurate

Panel-based genetic diagnostic testing for inherited eye disease proves highly accurate
2014-11-20
BOSTON (Nov. 20, 2014) Investigators at Massachusetts Eye and Ear and Harvard Medical School Department of Ophthalmology and colleagues reported the development and characterization of a comprehensive genetic test for inherited eye disorders in the online version of the Nature journal Genetics In Medicine today. The Genetic Eye Disease (GEDi) test includes all of the genes known to harbor mutations that cause inherited retinal degenerations, optic atrophy and early onset glaucoma. These disorders are important causes of vision loss, and genetic treatments such as gene ...

Revealing political partisanship a bad idea on resumes

2014-11-20
DURHAM, N.C. -- Displaced political aides looking for a new, nonpartisan job in the wake of the midterm power shuffle may fare better if they tone down any political references on their resumes, finds a new study from Duke University. The study found that applicants who shared the minority partisan view of voters where a resume was sent were less likely to receive a callback from an employer than a candidate with a neutral resume. Sharing information in line with the majority partisan view didn't give candidates an advantage, however. "Our results showed that individuals ...

Unstable child care can affect children by age 4

Unstable child care can affect children by age 4
2014-11-20
A new study from UNC's Frank Porter Graham Child Development Institute (FPG) reveals that disruptions in child care negatively affect children's social development as early as age 4. However, the study also shows that the effects of child care instability are not unduly large--and some types of instability appear to have no negative impact on children. "Our findings showed that when young children moved between child care settings, these transitions negatively affected their social adjustment," said FPG investigator Mary Bratsch-Hines. "But when children had a history ...

Research finds tooth enamel fast-track in humans

2014-11-20
The research found that incisor teeth grow quickly in the early stages of the second trimester of a baby's development, while molars grow at a slower rate in the third trimester. This is so incisors are ready to erupt after birth, at approximately six months of age, when a baby makes the transition from breast-feeding to weaning. Weaning in humans takes place relatively early compared to some primates, such as chimpanzees. As a result, there is less time available for human incisors to form, so the enamel grows rapidly to compensate. This research can increase our understanding ...

Caffeine counters cocaine's effects on women's estrus cycles

Caffeine counters cocaines effects on womens estrus cycles
2014-11-20
New Rochelle, NY, November 20, 2014-Women are more sensitive to the effects of cocaine and more susceptible to cocaine abuse than men. Cocaine's ability to disrupt a woman's estrus cycle may explain the sex differences in cocaine addiction, and new evidence that caffeine may be neuroprotective and able to block cocaine's direct effects on the estrus cycle reveals novel treatment possibilities, according to an article published in Journal of Caffeine Research: The International Multidisciplinary Journal of Caffeine Science, a peer-reviewed journal from Mary Ann Liebert, ...

Darwin 2.0

Darwin 2.0
2014-11-20
Birds that are related, such as Darwin's finches, but that vary in beak size and behavior specially evolved to their habitat are examples of a process called speciation. It has long been thought that dramatic changes in a landscape like the formation of the Andes Mountain range or the Amazon River is the main driver that initiates species to diverge. However, a recent study shows that speciation occurred much later than these dramatic geographical changes. Researchers from LSU's Museum of Natural Science have found that time and a species' ability to move play greater parts ...

Education empowers Canadians but raises risks of overwork and work-family stress

2014-11-20
The higher your level of education, the greater your earnings and your sense of "personal mastery" or being in control of your fate, University of Toronto researchers say. But wait: there's a downside. Professor Scott Schieman, Canada Research Chair in the Social Contexts of Health, and PhD student Atsushi Narisada investigated the adverse effects associated with attaining a high degree of mastery. Using the Canadian Work, Stress, and Health Study (CANWSH), a national sample of Canadian workers, the researchers measured proficiency, or mastery, by asking study participants ...

LAST 30 PRESS RELEASES:

NJIT research team discovering how fluids behave in nanopores with NSF grant

New study shows association of historical housing discrimination and shortfalls in colon cancer treatment

Social media use may help to empower plastic surgery patients

Q&A: How to train AI when you don't have enough data

Wayne State University researchers uncover potential treatment targets for Zika virus-related eye abnormalities

Discovering Van Gogh in the wild: scientists unveil a new gecko species

Small birds spice up the already diverse diet of spotted hyenas in Namibia

Imaging detects transient “hypoxic pockets” in the mouse brain

Dissolved organic matter could be used to track and improve the health of freshwaters

Indoor air quality standards in public buildings would boost health and economy, say international experts

Positive associations between premenstrual disorders and perinatal depression

New imaging method illuminates oxygen's journey in the brain

Researchers discover key gene for toxic alkaloid in barley

New approach to monitoring freshwater quality can identify sources of pollution, and predict their effects

Bidirectional link between premenstrual disorders and perinatal depression

Cell division quality control ‘stopwatch’ uncovered

Vaccine protects cattle from bovine tuberculosis, may eliminate disease

Andrew Siemion to receive the SETI Institute’s 2024 Drake Award

New study shows how the Crimean-Congo hemorrhagic fever virus enters our cells

Neoadjuvant chemotherapy proves effective for locally advanced penile squamous cell carcinoma

Study flips treatment paradigm in bilateral Wilms tumor, shows resistance to chemotherapy may point toward favorable outcomes

Doctors received approximately $12.1 billion from drug and device makers between 2013-2022

Discovery suggests new strategy against follicular lymphoma

Making the future too bright: how wishful thinking can point us in the wrong direction

Ochsner Health named to Newsweek’s America’s Greatest Workplaces 2024 for Job Starters

Three-year study of young stars with NASA’s Hubble enters new chapter

North Carolina takes the lead in PFAs research with Collaboratory’s $3 million investment to expand the state’s research capacity

Is it the school, or the students?

Exploring the relationship between HIV pre-exposure prophylaxis and the incidence of chlamydia, gonorrhea and syphilis – findings from Denmark

Music: Song lyrics have become simpler and more repetitive since 1980

[Press-News.org] The STING of radiation
Ludwig researchers reveal the molecular mechanisms by which the immune system is activated against tumors treated with radiation